Transcripts
Acadia Pharmaceuticals (ACAD) earnings call transcripts
Earnings call transcripts for Acadia Pharmaceuticals Inc., with a summary, the guidance given, and what analysts pressed on.
- Q2 2026 earnings call
Commercial momentum, especially sticks, strengthened confidence while Europe and a binary ADP readout define the next catalysts. 40% of U.S.
Aug 04, 2026Confident0.82